PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.77%
Revenue growth under 50% of MCHP's 10.82%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.40%
Gross profit growth under 50% of MCHP's 15.09%. Michael Burry would be concerned about a severe competitive disadvantage.
45.05%
EBIT growth below 50% of MCHP's 140.04%. Michael Burry would suspect deeper competitive or cost structure issues.
45.05%
Operating income growth under 50% of MCHP's 132.00%. Michael Burry would be concerned about deeper cost or sales issues.
28.03%
Net income growth under 50% of MCHP's 87.97%. Michael Burry would suspect the firm is falling well behind a key competitor.
23.08%
EPS growth under 50% of MCHP's 70.34%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
23.08%
Diluted EPS growth under 50% of MCHP's 70.34%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-5.09%
Share reduction while MCHP is at 0.33%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-5.09%
Reduced diluted shares while MCHP is at 0.33%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-29.19%
Dividend reduction while MCHP stands at 10.17%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-105.00%
Negative OCF growth while MCHP is at 33.85%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
1.87%
FCF growth under 50% of MCHP's 34.43%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
44.13%
10Y revenue/share CAGR at 75-90% of MCHP's 51.09%. Bill Ackman would press for new markets or product lines to narrow the gap.
38.38%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
15.51%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-37.91%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-921.03%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-229.33%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
577.65%
5Y dividend/share CAGR above 1.5x MCHP's 175.02%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
527.45%
3Y dividend/share CAGR above 1.5x MCHP's 81.65%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
9.20%
AR growth well above MCHP's 10.99%. Michael Burry fears inflated revenue or higher default risk in the near future.
-1.72%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.68%
Positive asset growth while MCHP is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
15.26%
Positive BV/share change while MCHP is negative. John Neff sees a clear edge over a competitor losing equity.
-8.56%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-10.90%
We cut SG&A while MCHP invests at 4.80%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.